Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer EntitiesWolfgang P. Fendler, Rainer Hamacher, Lale Umutlu et al.|Clinical Cancer Research|2022Cited by 145
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor EntitiesNader Hirmas, Wolfgang P. Fendler, Rainer Hamacher et al.|Journal of Nuclear Medicine|2022Cited by 68
Superior Tumor Detection for<sup>68</sup>Ga-FAPI-46 Versus<sup>18</sup>F-FDG PET/CT and Conventional CT in Patients with CholangiocarcinomaKim M. Pabst, Wolfgang P. Fendler, Marija Trajkovic‐Arsic et al.|Journal of Nuclear Medicine|2023Cited by 63
Oncologic Staging with<sup>68</sup>Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than<sup>18</sup>F-FDG PET/CTTristan T. Demmert, Wolfgang P. Fendler, Helena Lanzafame et al.|Journal of Nuclear Medicine|2023Cited by 23